Exhaled nitric oxide levels in non-allergic and allergic mono- or polysensitised children with asthma

M Silvestri1, F Sabatini, D Spallarossa

  • 1Pulmonary Division, G. Gaslini Institute, Largo G Gaslini 5, 16148 Genoa, Italy.

Thorax
|October 20, 2001
PubMed

Insights

Allergic children with mild asthma exhibit higher blood eosinophilia and fractional exhaled nitric oxide (FENO) levels, indicating increased inflammation compared to non-allergic asthmatics. These markers suggest a greater inflammatory component in allergic asthma, even with similar lung function.

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Clinical Immunology

Background:

  • Allergic children with mild asthma often show elevated fractional exhaled nitric oxide (FENO) and blood eosinophilia, reflecting disease intensity.
  • The study aimed to compare FENO levels and blood eosinophilia between allergic and non-allergic asthmatic children.

Purpose of the Study:

  • To investigate differences in FENO levels and blood eosinophilia intensity in allergic versus non-allergic asthmatic children.
  • To correlate these inflammatory markers with asthma severity and sensitization status.

Main Methods:

  • 112 children with mild intermittent asthma underwent methacholine bronchial challenge.
  • Participants were categorized into non-sensitized (n=56) and allergic (n=56) groups based on skin prick tests and RAST.
  • A control group of 19 healthy children was included for comparison.

Main Results:

  • Allergic asthmatic children showed significantly higher blood eosinophilia (p=0.0001) and FENO levels (p=0.0001) compared to non-allergic asthmatics.
  • Lung function (FEV1, FVC, FEF25-75%) and bronchial reactivity were similar across groups.
  • Significant correlations between blood eosinophilia and FENO were observed in allergic and polysensitized children.

Conclusions:

  • Children with mild asthma have a higher inflammatory component if they are allergic compared to non-allergic subjects.
  • FENO and blood eosinophilia serve as valuable biomarkers for assessing allergic inflammation in pediatric asthma.
Abstract

Related Concept Videos

Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...